Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Harris

Showing results (41-50 of 682) with videos related to

Pageof 69
Sort By:
Cancer Treatment Reviews|April 1, 1993
The role of topoisomerase II alpha and beta in drug resistanceD Hochhauser, A L Harris
Annals of Internal Medicine|July 1, 1981
Reactions to ellipticinium acetateA L Harris, D Spence
Seminars in Cancer Biology|December 1, 1992
Anticancer strategies involving the vasculature: vascular targeting and the inhibition of angiogenesisR Bicknell, A L Harris
European Journal of Cancer (Oxford, England : 1990)|April 1, 1990
Enhancement of Adriamycin cytotoxicity in a multidrug resistant Chinese hamster ovary (CHO) subline, CHO-Adrr, by toremifene and its modulation by alpha 1 acid glycoproteinM Chatterjee, A L Harris
Current Opinion in Oncology|January 1, 1996
Mechanisms and therapeutic implications of angiogenesisR Bicknell, A L Harris
The Cancer Journal From Scientific American|August 5, 1998
New developments in angiogenesis: a major mechanism for tumor growth and target for therapyA Jones, A L Harris
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
Growth factors and angiogenesis in breast cancerA L Harris, E Horak
Current Opinion in Oncology|February 1, 1992
Cell adhesion molecules and cancerJ Fawcett, A L Harris
Anticancer Research|March 23, 2002
Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancerA Giatromanolaki, A L Harris
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic toolG Gasparini, A L Harris
Pageof 69

Showing results (41-50 of 682) with videos related to

Sort By:
Pageof 69
Cancer Treatment Reviews|April 1, 1993
The role of topoisomerase II alpha and beta in drug resistanceD Hochhauser, A L Harris
Annals of Internal Medicine|July 1, 1981
Reactions to ellipticinium acetateA L Harris, D Spence
Seminars in Cancer Biology|December 1, 1992
Anticancer strategies involving the vasculature: vascular targeting and the inhibition of angiogenesisR Bicknell, A L Harris
European Journal of Cancer (Oxford, England : 1990)|April 1, 1990
Enhancement of Adriamycin cytotoxicity in a multidrug resistant Chinese hamster ovary (CHO) subline, CHO-Adrr, by toremifene and its modulation by alpha 1 acid glycoproteinM Chatterjee, A L Harris
Current Opinion in Oncology|January 1, 1996
Mechanisms and therapeutic implications of angiogenesisR Bicknell, A L Harris
The Cancer Journal From Scientific American|August 5, 1998
New developments in angiogenesis: a major mechanism for tumor growth and target for therapyA Jones, A L Harris
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
Growth factors and angiogenesis in breast cancerA L Harris, E Horak
Current Opinion in Oncology|February 1, 1992
Cell adhesion molecules and cancerJ Fawcett, A L Harris
Anticancer Research|March 23, 2002
Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancerA Giatromanolaki, A L Harris
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic toolG Gasparini, A L Harris
Pageof 69